Catalyst Wire Dossier Catalyst Wire Dossier

recombinant coronavirus vaccine (CHO cell) for COVID-19

· Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant coronavirus vaccine (CHO cell) for COVID-19, covering 2022-02-22 to 2022-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) [Phase 3]

See pricing